Current Research Studies
A MASTER PHASE 1/2/3 PROTOCOL TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF BIVALENT BNT162b2 RNA-BASED VACCINE CANDIDATE(S) IN HEALTHY CHILDREN
C4591048_OMI
What is the goal of the study?
A multi-pronged, multi-phased study looking at the use of a bivalent RNA based COVID vaccine in children.
Who can participate in the study?
Please contact the study team listed below to learn more.